Authors: | Kelsen, D. P.; Hilaris, B.; Martini, N. |
Article Title: | Neoadjuvant chemotherapy and surgery of cancer of the esophagus |
Abstract: | Neoadjuvant, or preoperative, chemotherapy for esophageal cancer has become an area of increasing interest because of the failure of conventional therapy (surgery or radiation) to improve disease‐free or overall survival. Several autopsy series have demonstrated that, in many symptomatic western patients, esophageal cancer is a systemic disease. Neoadjuvant chemotherapy thus, in theory, allows a simultaneous attack on both the primary and metastatic disease. A number of single‐arm, phase n multi‐modality trials have been completed. Toxicities of chemotherapy, while substantial, have been tolerable. With careful attention to detail, operative morbidity and mortality has not been increased. Large‐scale randomized trials are needed to evaluate the impact of this technique on disease‐free and overall survival. Copyright © 1986 Wiley‐Liss, Inc., A Wiley Company |
Keywords: | cancer chemotherapy; review; cisplatin; fluorouracil; cancer combination chemotherapy; cancer radiotherapy; combined modality therapy; etoposide; antineoplastic combined chemotherapy protocols; radiotherapy; vincristine; vinblastine; postoperative complications; bleomycin; esophagus resection; mitomycin c; vindesine; esophagus cancer; esophagus; therapy; esophageal neoplasms; intravenous drug administration; mitoguazone; preoperative chemotherapy; multimodality treatment; human |
Journal Title: | Seminars in Surgical Oncology |
Volume: | 2 |
Issue: | 3 |
ISSN: | 8756-0437 |
Publisher: | John Wiley & Sons |
Date Published: | 1986-01-01 |
Start Page: | 170 |
End Page: | 176 |
Language: | English |
DOI: | 10.1002/ssu.2980020310 |
PUBMED: | 3330276 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Article -- Export Date: 18 August 2021 -- Source: Scopus |